Category: CovidienSyndicate content

Covidien acquires Sapheon and its VenaSeal varicose vein treatment

August 28, 2014 by Brad Perriello

Covidien acquires Sapheon and its minimally invasive VenaSeal device for treating varicose veins for an undisclosed amount.

Covidien acquires Sapheon and its VenaSeal varicose vein treatment

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Another Covidien shareholder sues over Medtronic deal

August 27, 2014 by Arezu Sarvestani

Yet another shareholder sues Covidien and its leaders, accusing them of short-changing investors in the $43 billion acquisition by Medtronic.

Another Covidien shareholder sues over Medtronic deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien acquires Reverse Medical | The week in medtech M&A

August 27, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Covidien snaps up Reverse Medical; Report: Medtronic butts heads with shareholders at annual meeting; Allergan can't delay shareholder vote on hostile Valeant bid; Report: Allergan solicits Salix in bid to stymie hostile Valeant takeover; Report: Endo Health puts AMS up for sale

Covidien snaps up Reverse Medical

August 22, 2014 by Brad Perriello

YYmeta

New roster: Medtronic, Covidien reveal regional integration teams

August 26, 2014 by Arezu Sarvestani

Medtronic and Covidien reveal the line-up of leaders slated to guide integration of the companies' regional divisions ahead of their $43 billion merger.

New roster: Medtronic, Covidien reveal regional integration teams

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic CEO targets 40% share of patient monitoring market after Covidien deal's close

August 26, 2014 by Brad Perriello

Medtronic CEO Omar Ishrak tells employees that its pending combination with Covidien lays the table for taking a 40% share of the patient monitoring market.

Medtronic CEO targets 40% share of patient monitoring market after Covidien deal's close

FDA grants Philips clearance for 3D TAVI software | Regulatory news for the week of August 25, 2014

August 26, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Philips wins FDA nod for 3D TAVI planning software; Direct Flow wins CE Marks for TAVI device; FDA OKs return of Covidien's Pipeline embolism device; FDA delays UDI rule for contacts, intraocular lenses; Cardiovascular Systems recalls some Diamondback devices on embolism risk

Philips wins FDA nod for 3D TAVI planning software

August 21, 2014 by Brad Perriello

Standard & Poor's maintains credit watch on Medtronic over Covidien buy

August 22, 2014 by Brad Perriello

Standard & Poor's Ratings Services maintains a credit watch on Medtronic over its $43 billion buyout of Covidien, pending Medtronic's ability to control its indebtedness.

Standard & Poor's puts credit watch on Medtronic over Covidien buy

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp